Showing 9761-9770 of 18100 results for "".
- T-Cell Immunity Persists in Rituximab-Treated RA Patients, Recasting the Role of COVID-19 Vaccineshttps://reachmd.com/news/t-cell-response-in-sars-cov-2-vaccination-persistence-in-rituximab-treated-rheumatoid-arthritis/2474224/In the ongoing effort to optimize COVID-19 protection for immunocompromised patients, new research is shifting the spotlight toward T-cell immunity. For rheumatoid arthritis patients treated with rituximab—a B-cell depleting therapy—recent findings reveal that vacc
- Cancer Immunotherapy: Efficacy Across Age Groupshttps://reachmd.com/news/cancer-immunotherapy-efficacy-across-age-groups/2474232/New studies demonstrate that immune checkpoint inhibitors provide significant benefits equally to both older and younger cancer patients. These findings challenge longstanding beliefs about age-related immune decline and introduce more inclusive therap
- Untangling the Link Between Gynecological Cancers and Female Infertilityhttps://reachmd.com/news/untangling-the-link-between-gynecological-cancers-and-female-infertility/2474213/Could the genetic architecture of infertility shed light on cancer risk—or vice versa? A new study employing bidirectional Mendelian randomization (MR) analysis takes a closer look at this question, exploring whether female infertility is causally linked to the dev
- Increased Cost Diminishes Sunscreen Use: Reporthttps://reachmd.com/news/cost-influences-sunscreen-use-raising-skin-cancer-risk-study-shows/2474206/Patients use less sunscreen when it’s more expensive, according to a brief report in the Journal of the American Academy of Dermatology. Researchers from the University of California, Sa
- Lipid Metabolism and Immune System Aging: Exploring the Role of Key Enzymeshttps://reachmd.com/news/lipid-metabolism-and-immune-system-aging-exploring-the-role-of-key-enzymes/2474233/Emerging research reveals that the enzyme ELOVL2, crucial in lipid metabolism, is linked to reduced immune cell production in older adults, heightening infection susceptibility. This research is vital for fields such as Allergy, Asthma, and Immu
- Long-term Disease Control in NSCLC: Outcomes Post-Immunotherapy Discontinuationhttps://reachmd.com/news/long-term-disease-control-in-nsclc-outcomes-post-immunotherapy-discontinuation/2474201/Retrospective studies have highlighted that a segment of non-small cell lung cancer (NSCLC) patients who cease immunotherapy due to immune-related adverse events (irAEs) continue to sustain disease control. This exploration delves into clinical observations and potential im
- Balancing High Performance and Safety: Mitigating Injury Risks in Young Equestrianshttps://reachmd.com/news/sports-injury-risk-assessment-and-functional-movement-analysis-in-young-elite-equestrian-athletes/2474164/Young equestrians training at elite levels walk a delicate line between maximizing performance and safeguarding their long-term musculoskeletal health. As competition intensifies and training regimens grow increasingly complex, the risk of movement-related injuries
- Inflammatory Pathways: The Rheumatoid Arthritis–Lung Cancer Connectionhttps://reachmd.com/news/inflammatory-pathways-the-rheumatoid-arthritislung-cancer-connection/2474161/Rheumatoid arthritis (RA) is classically recognized for its destructive effects on joints, but its systemic impact stretches far beyond the synovium. Among the most pressing concerns is the increased incidence of lung cancer in patients with RA—a link that continue
- Male Survivors of Intimate Partner Violence Face Barriers to Support, SFU Study Findshttps://reachmd.com/news/male-survivors-of-intimate-partner-violence-face-barriers-to-support-sfu-study-finds/2474197/While public discourse around intimate partner violence (IPV) has increasingly highlighted the experiences of women, new research from Simon Fraser University reveals a troubling oversight: male survivors often go unsupported, largely due to a lack of services and
- Stroke and SARS-CoV-2: New Data Reveals Outcomes in Intracerebral Hemorrhagehttps://reachmd.com/news/covid-19-and-nontraumatic-intracerebral-hemorrhage-outcomes-analysis/2474163/As the world continues to assess the collateral impacts of the COVID-19 pandemic, new evidence from the National Inpatient Sample (NIS) draws a troubling link between SARS-CoV-2 infection and worsened outcomes in patients with nontraumatic intracerebral hemorrhage